chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial and follow up information has been received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, drug reactions and allergies were not reported. On 10-SEP-2015, the patient received an improperly stored dose of VAQTA, lot # K007827, expiration date 09-DEC-2016 (dose, frequency and route were not reported). No concomitant medications were reported. No adverse effect was reported. No product quality complaint was involved. This is one of several reports from the same source. Additional information has been requested.
he was really weak; could hardly walk; very shaky; afraid that he may fall, but he did not; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (he was really weak), GAIT DISTURBANCE (could hardly walk), TREMOR (very shaky) and FEELING ABNORMAL (afraid that he may fall, but he did not) in a 93-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 049L21A, 027H21B, 045A21A and 012M20A) for COVID-19 vaccination.     Patient had no allergies to medications, food and other products. No other vaccines were given within 1 month prior to Moderna COVID-19 vaccine.  Concurrent medical conditions included Autoimmune disorder (Start Date: 4 years ago, (unknown but related to arthritis), Stable, no relapses in last 4 years), Congestive heart failure (Stable) and Prostate cancer. Concomitant products included FUROSEMIDE for Congestive heart failure, OMEPRAZOLE, TAMSULOSIN, CARVEDILOL, ATORVASTATIN, ENALAPRIL and SERTRALINE for an unknown indication.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 04-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-May-2022, the patient experienced ASTHENIA (he was really weak), GAIT DISTURBANCE (could hardly walk), TREMOR (very shaky) and FEELING ABNORMAL (afraid that he may fall, but he did not). On 10-May-2022, ASTHENIA (he was really weak), GAIT DISTURBANCE (could hardly walk), TREMOR (very shaky) and FEELING ABNORMAL (afraid that he may fall, but he did not) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 test: positive (Positive) Positive in late NOV- early DEC2021.   Concomitant drug included injection for prostate cancer.  The 2nd day, after receiving the 2nd booster dose patient was still weak, but his symptoms were improving. By the 3rd day, patient was much better, and his symptoms had resolved.  AE did not cause patient to seek medical care, patient rested all day.  No treatment medication was reported by the reporter.   This case was linked to MOD-2022-564299 (Patient Link).
Day after vaccine had headache, extremely tired, chills.  Felt better next day. Morning of Day 8  after vaccine developed sore left arm and a round red circle around injection site.  Soreness went up to shoulder especially when moving and lifting arm, had headache and tired.  Today arm is feeling better and red circle disappeared. Still some soreness but much improved.   Will monitor and request 2nd shot in right arm
3rd morning after 2nd shot (5-1-21),I  developed sharp pain from nerve compression in lower spine while sitting. No reason has been determined for this happening. Each day the pain got worse and the 2nd day after that (5-3-21) , I could no longer even lift my left leg. The pain was extreme in my lower back and left hip. I went to urgent care and the doctor said it was a compressed spinal nerve with inflammation. He gave me a shot of an NSAID near the spine and put me on a 5 day course of Prednisone. He also prescribed pain killers and muscle relaxant to use as needed.
Patient calls pharmacy 2 hours after SHINGRIX administration to patient's right deltoid muscle reporting concerns of itchy red rash developing on feet. Pharmacist confirms okay to use hydrocortisone cream and BENADRYL to help reaction; confirms no trouble breathing or shortness of breath; asks patient to follow up with pharmacist or doctor if worsening. Patient arrives at pharmacy hour later showing pharmacist symptoms. Both feet, lower calves/shins, upper knee and leg of left leg now developed bright red, swollen, puffy, itchy. Symptoms not being subsided by OTC medications. Still no reports of trouble breathing. Pharmacist instructed patient and friend/driver to report to emergency room, gave them administration information sheet and CDC SHINGRIX guide to give to ER.
Red, itchy, and hot rash at injection site (left upper arm) 1 week (7 days) after first does of Covid-19 Moderna vaccination. The rash was treated with Benedryl, ice and Tylenol. The rash occured for approximately two days and then went away. The rash did NOT occur after the second dose in the right upper arm injection site.
Achy; headache; Chills; Nauseous; This is a spontaneous report from a non-contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration on 23Mar2021 at 17:00 (at the age of 30-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021 at 06:00, the patient experienced achy, headache, chills and nauseous. The clinical outcome of the events achy, headache, chills and nauseous was resolved on an unknown date in 2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
pt recvd flu vax & w/in 48 hrs pt devel soreness @ the inject site;
stomach upset Narrative: Patient reported "stomach feels off" while in the monitoring area after Covid vaccination #1. Denied any other s/sx, no visual changed, no checkst pain stated before BP was assessed. Patient reported the BP was going to be high as he has "White coat syndrome" and he and his BP was monitoring BP at home. He denied SOB, CP, radiating arm pain, headach or jaw pain. BP was 200/100@15:57 and 182/107@1605, HR 106 an 103. Educa3tio was provided to patient on when to call 911, pt verbalized understand and will f/u with PCP. Patient was appreciative for the concern and stated he will f/u with PCP and check BP when he is home, along with alerting PCP of BP reading. Patient declined any further intervention while at the Covid vaccination clinic. Advised as above on s/sx to utilize 911.
Severe dysphoria, borderline suicidal ideation, and craving for euphorigenic drugs.
My daughter started having "the shakes" after her 6 month vaccinations. We were never made aware of the dangers of vaccinations until recently. Between ages 1-3 she had continous ear and sinus infections. We recently discovered that she has Pervasive Developmental Disorder - not otherwise specified (Autism Spectrum Disorder) along with hearing sensitivity, phonological disorder, and ADHD. She has also been diagnosed as being toxic for heavy metals including, but not limited to Mercury and Lead. She also has vision problems.  Information received from medical redords states, limp, ataxia, agitated.
This spontaneous report as received from a health professional to a 12 month old patient. On 09-JAN-2014 the patient was vaccinated with a dose of PROQUAD (lot number reported as J008572, expired date 12-JAN-2015) (dosage information and route unspecified) and a dose of VARIVAX (merck) (lot number reported as G17340, expired date 20-JAN-2015) (dosage information and route unspecified), instead of M-M-R II and VARIVAX (merck). The reporter stated that this error was not due to product confusion. No adverse effect had been observed or reported. Additional information has been reported.
herpes zoster; Information has been received from a lawyer concerning a case in litigation and refers to a female patient of an unknown age. The patient's concurrent conditions, medical history, historical drugs and concomitant therapies were not reported.   In on around 22-SEP-2015, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) for prevention of shingles (dose, route, lot number and expiration date were not reported).  On an unknown date (reported as "shortly after receiving zoster vaccine live (ZOSTAVAX)"), she experienced multiple, severe and painful rashes on the back and buttocks, she was diagnosed with herpes zoster. The patient's symptoms had resulted in physical limitations not present prior to using zoster vaccine live (ZOSTAVAX). As a result of zoster vaccine live (ZOSTAVAX), the patient had severe and permanent personal injuries. The patient suffered serious, progressive, permanent and incurable injuries. The outcome of herpes zoster was not recovered. The reporter considered herpes zoster to be related to Zoster Vaccine Live (ZOSTAVAX). The event was considered a disabling event.
Within a couple of hours post shot I started getting a headache and had some stiffness and pain in my head and jaw. When I woke up the next morning (18 hrs post shot)  I was running a fever (highest documented was 100.4), body aches (felt like I had been hit by a truck), pounding headache and chills (couldn't get warm despite several blankets). This continued all day (hours 18-34 post shot). Fever broke around hour 34 and at hour 42 post shot all symtpoms have resolved.
Mom reported on 6/26/13 that within 5 hrs from administration of PEDIARIX (DTaP, IPV, HBV) #1, Hib PEDVAX #1 and ROTARIX #1 pt had temp of 103 degrees and could not take bottle. Mom took to ER and was told it may be from immunizations. Given IV fluid for dehydration. Stayed in hosp x 2 days for IVF and fussing.
This spontaneous case reported by a consumer, describes the occurrence of insomnia (trouble sleeping), myalgia (muscle pain/muscle pain in legs) and arthralgia (joint pain) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported.  On Feb 19, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 19, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 20, 2021, patient experienced insomnia (trouble sleeping), myalgia (muscle pain/muscle pain in legs) and arthralgia (joint pain). At the time of the report,  insomnia (trouble sleeping), myalgia (muscle pain/muscle pain in legs) and arthralgia (joint pain) outcome: unknown. No concomitant medication or treatment information provided.
This spontaneous report as received from a 58-year-old male patient refers to himself. Patient's medical history included herpes zoster. Drug reactions and allergies were not reported. In 2012, the patient was vaccinated with ZOSTAVAX, subcutaneous (dose, lot# and expiration date were not reported. No concomitant medications were reported. Subsequently, on an unspecified date 2012, the patient experienced headache for about a month and reported that ever since then he did not feel fully healthy. The patient also reported since then he had a low rate virus of shingles but no rashes appeared. On an unknown date, the patient went to his doctor and received a vaccine for congestion but that made his shingles feel a lot worse. He was going to visit his doctor on Thursday at the time of report. The outcome of adverse events as unknown. The relatedness between the adverse events and ZOSTAVAX was not reported. Additional information has been requested.
Hands swelling, itching, whelps on hands, behind knees, hips, (L) buttocks, cont. episodes of hives with itching x 1 wk., inj. site, swollen red, tender on 10/18/12.
pt recvd vax & devel large areas of redness & swelling which were hot to touch on the arm following vaax;
Information has been received from a nurse concerning a patient who was vaccinated with a dose of Rotateq (human bovine). The nurse reported that the patient subsequently developed diarrhea and fever. It was unknown if medical attention was sought. At the time of this report, the outcome was unknown. Additional information has been requested.
Patient was inadvertently given her Moderna COVID-19 booster dose of 0.25mL 25 days early. Second dose of primary series was 6/7/21 and booster was administered 11/12/21. Patient was vaccinated at an outreach clinic in low income housing and had lost her card. She believed she had gotten her second dose in April, but was incorrect.
Information has been received from a physician, for GARDASIL, a Pregnancy Registry product, concerning a 24 year old female patient with allergy to KEFLEX and no pertinent medical history who on 03-MAY-2012 was vaccinated with the first dose of GARDASIL, intramuscular (dose and lot # not provided). On 18-MAY-2012, the patient had her last menstrual period (LMP). On 02-JUL-2012 the patient was vaccinated with the second dose of GARDASIL intramuscular (dose and lot # not provided). No concomitant medications were reported. The physician reproted that on July 2012 "sometime after 02-JUL-2012", the patient discovered that she was pregnant via a home pregnancy test. The estimated date (EDD) was 22-FEB-2013. On unknown dates, laboratory tests included cell blood count (CBC), "NRH", sexually transmitted disease (STD) cultures, results were not provided. The patient sought medical attention, she went to the physician's office. Follow-up information was received from the physician. She reported that this patient did not complete her OB care at this office so she has no information to share about the patient's delivery or post-partum course. She also reported that she did not have any information on the new physicians that the patient may have gone to. Additional information is not expected.
1st vaccine looked brown in color.; 1st vaccine looked brown in color.; 1st vaccine looked brown in color.; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT COLOUR ISSUE (1st vaccine looked brown in color.), WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (1st vaccine looked brown in color.) and PRODUCT QUALITY ISSUE (1st vaccine looked brown in color.) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003B21A and 001C21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 22-Mar-2021, the patient experienced PRODUCT COLOUR ISSUE (1st vaccine looked brown in color.), WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (1st vaccine looked brown in color.) and PRODUCT QUALITY ISSUE (1st vaccine looked brown in color.). At the time of the report, PRODUCT COLOUR ISSUE (1st vaccine looked brown in color.), WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (1st vaccine looked brown in color.) and PRODUCT QUALITY ISSUE (1st vaccine looked brown in color.) outcome was unknown. Not Provided          No concomitant medications were provided. No Treatment history was provided.
Mom reports a rash starting 2 days after imm.starting on arms and chest, on 09/05/06 became worse  and by 09/09/06 MD put on prednison as developed into hives and welts all over body. MD extended the Rx on 09/12/06 as rash continues.
Pt watching TV, experienced sweating, chills, extreme nausea, and shakiness.  Patient went to Emergency dept.  BP was 187/71 and all tests were clear.  Patient was kept for approx 5 hours and released with no further symptoms.
Information has been received from a nurse referring to a patient of unknown age and gender. The patient's concurrent condition, medical history and concomitant therapy were not reported. On an unknown date, the patient was vaccinated with improperly stored dose of ROTATEQ (lot # M031651, expiration date: 30-MAR-2018, dose, frequency and route were unknown) for prophylaxis(incorrect product storage). The ROTATEQ was exposed to 31 Fahrenheit degree or colder for a time frame of 13 hours. Data logger was involved. No adverse effects reported.; Sender's Comments: US-0009507513-1707USA010905:
I was fine the 1st couple of days, but on the 3rd, I started feeling sick. I feel like I was exposed from my boyfriend, but I wasn't sure. On the 5th, I had every symptom. I was off work until the 12th. I came home and took care of myself.
Swelling and pain to right armpit lymph nodes.  First small lump discovered 10 days post-2nd vaccination.  Swelling increased as did the quantity of swollen masses.  Largest of which is approximately 1.25" in diameter with noted redness and pain.
Patient complained of inflammation at the injection site. No hives, swelling of the lips or tongue or difficulty breathing.
The day after my 2nd vaccine, I experienced significant unsteadiness in walking. It was as if I was 'drunk'. I couldn't walk a straight line and had to hold onto something to move from point A to point B . This lasted for about 5 days and was most severe when I had to get up in the night. Very scary situation. I didn't know if I was having a stroke or...? Because I was being treated by a pain specialty group and was taking Gabapentin (for about 3 months...with no side effects, I thought that might be the problem so  with their guidance, I slowly reduced the dosage - without significant impact.
April 16 th she started getting blotches on face and arms and upper thighs. It would itch and burn. A few day later she got itching and burning in the mouth. They have come and gone . Patches of bumps on hands and feet.
Redness and lumps on left arm that moved down pass elbow. Tendons tightening and development of Trigger Finger.
Running nose that bled; Sore throat; Weakness; anal leakage; upset stomach; Sweating perfusely; thirst; dizziness.
A non-serious spontaneous report of burning nose and developed a scab in the nose has been received from a registered nurse concerning a five-year-old female, subsequent to receiving FLUMIST. No medical history or concomitant medications were reported. The patient received FLUMIST nasally on 21-Sep-2009. On 21-Sep-2009, after receiving FLUMIST the patient developed burning in the nose and a scab in the nose. No other symptoms were reported. At a medical visit on 17-Sep-2010, to obtain this years flu vaccine, the 2009 events were reported and the reporter indicated the patient had received no medical attention for the events and the events were resolved.
On the next day I started feeling itchy on my chest. It felt almost like a heat rash. I also had body aches but no fever. I felt very exhausted. Recently like 3 weeks ago I stared having an acapt situation. I never had problems with my heart. I don't know if it has to do with the vaccine or my age. I will be seeing a doctor in regards of this issue.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAX (dose, route, lot number and expiration date not reported). There was no concomitant medication reported. The pharmacist states that in all years he has been administering ZOSTAVAX he "has seen only one case in which a patient reported a case of shingles after receiving ZOSTAVAX". Pharmacist reported that the situation occurred in an unknown date in approximately 2009 ("four or five years ago"). Pharmacist remembered that the patient developed a mild rash around her neck and on the back of her head. Patient did not receive treatment and patient reported to the pharmacist that she was "glad that she received the vaccine", her healthcare provider had told her that if she had not received ZOSTAVAX, her case of shingles "could have been much worse". Pharmacist reported that the patient developed this shingles-like rash "months after receiving the vaccine" and pharmacist believed that the patient made a full recovery on an unknown date. This is one of two reports from the same source. Additional information is not expected since the reporter stated that this was all information he can remember about this scenario and he would not be able to provide any other information in the future since he cannot remember the patient's name and it was so long ago.
Chills for 3-4 hours 12 hours after receiving shot.  Than sweats for a few hours until morning.  Slight headache, as well as slight nausea.  Slept on and off until 2:00 PM next day, then felt better and able to eat.
8 days after vaccine received left deltoid became red, swollen, warm to touch itchy and irritated.  I took Benadryl 25mg prior to sleep.  The next morning the site was still warm and irritated, swelling improved slightly.  By evening swelling and discomfort was gone.  The area stayed slightly reddened for a total of 4 days.
Very red arm in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Very red arm in the injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood disorder (Vonwillibrands type1 - a platelet disorder, cannot take aspirin).    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Very red arm in the injection site). On 09-Feb-2021, VACCINATION SITE ERYTHEMA (Very red arm in the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  pharmacist said to just put warm compresses, and then ice   This case was linked to MOD21-051822 (Patient Link).
Information has been received from a physician concerning a female who was vaccinated with a first dose of GARDASIL.  Subsequently the patient experienced an abscess or an infection at the injection site.  The physician reported that this is not a patient of hers and she heard about the experience from a third party.  Attempts to verify the existence of an identifiable patient has been unsuccessful.  No further information is available.
patient reported to the ED the morning after her vaccine .49-year-old female past medical migraines, GERD, allergic reactions presents to the ED for evaluation of allergic reaction.  Has a history of known reactions to the flu vaccine.  Yesterday she received the first dose of the Covid vaccine.  This morning she noticed the right side of her neck felt swollen.  Throughout the morning she has noticed that her throat feels full and so does her tongue.  Denies any swelling of the lips.  Denies any change in her voice quality.  Denies stridor or hoarseness.  Her right eye is also became somewhat swollen and difficult to open.  Denies drooling or trismus.  Denies recent fevers or chills.  Denies any rash or hives.  Denies itching.  Denies cough or audible wheezing.  Denies dyspnea.  Denies chest pain or palpitations.  Denies nausea or emesis.  Denies any dizziness or lightheadedness.  Denies any syncopal episode.
(L) arm sore since PCV13 given. Sore x 4 weeks. Initially swollen, hard and red at site. Now just painful at site. ROM is painful. Will be treated w/massage, ROM exercises.
Stomach ache, fever (102 degrees), chills, diarrhea, sweating, passed out. Call emergency services, Revived. Vital sign were good. Treating with fluid and Tylenol.  Called primary care doctor.
PER PATIENT,  PATIENT  HAS PAIN AT INJECTION SITE, MUSCLE PAIN, BACK PAIN ,FEVER AND FEEL HOT IN HER LUNGS